logo
13.6 billion years stormy glow-in-the-dark massive cloud found lurking neat Earth: Can it impact life on Earth

13.6 billion years stormy glow-in-the-dark massive cloud found lurking neat Earth: Can it impact life on Earth

Time of India06-05-2025

The universe contains secrets, many of which have remained undetected despite decades of research and space missions through powerful telescopes. Astronomy constantly reminds us that what we know is only a fraction of what lies out there. May it be rogue planets drifting alone in the dark or entire galaxies concealed behind curtains of cosmic dust, it all seems like a mysterious sojourn.
Occasionally, discoveries come not from the obvious but from what hides in plain sight. Such things, when something massive and cosmically ancient is suddenly found just next door, enhance our understanding of the cosmos even more.
Astronomers have now come across another surprising object, which is a massive molecular cloud, and that too in Earth's cosmic backyard, which has somehow remained invisible until now. Named Eos, this newly discovered structure has opened a fresh window into
star and planet formation
, right at the edge of our local space environment.
What have the scientists discovered?
Scientists have identified a colossal molecular cloud which is located just 300 light-years away from Earth. Despite being so close, this massive structure went unnoticed until now due to its unusually low hydrogen content, which made it nearly invisible using traditional observation techniques.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
The Cost Of Amusement Park Equipment From Mexico Might Surprise You
Amusement Park Equipment | search ads
Click Here
Undo
The discovery which was published on April 28, 2025, in Nature Astronomy, was possible through data collected from the Korean satellite STSAT-1. It is equipped with a
far-ultraviolet spectrograph
(FIMS-SPEAR), and the satellite was used to search for ultraviolet emissions from molecular hydrogen, a component that usually glows under ultraviolet light. And it worked.
A image provided by Thomas Müller (HdA/MPIA) and Thavisha Dharmawardena (NYU) shows, a newly discovered potentially star-forming cloud that is one of the largest structures in the sky. The cloud, named Eos, is chock-full of molecular hydrogen and possibly rife with star-forming potential in the future. (Thomas Müller (HdA/MPIA) and Thavisha Dharmawardena (NYU) via The New York Times) -- NO SALES; FOR EDITORIAL USE ONLY WITH NYT STORY SCI COSMIC CLOUD BY KATRINA MILLER FOR MAY 5, 2025. ALL OTHER USE PROHIBITED. --
'This is the first-ever molecular cloud discovered by looking for far-ultraviolet emission of molecular hydrogen directly,' said lead author Blakesley Burkhart from the Department of Physics and Astronomy at Rutgers School of Arts and Sciences in New Jersey. 'The data showed glowing hydrogen molecules detected via fluorescence in the far ultraviolet.'
According to Burkhart, "This cloud is literally glowing in the dark. It was kind of like just waiting to be explored. This opens up new possibilities for studying the molecular universe", as reported by Nature Astronomy, 2025.
What is special about this cloud?
What makes Eos especially interesting isn't just its proximity, but its huge size and structure. Weighing in at 3,400 times the mass of the Sun, Eos is one of the largest single formations ever seen in space. If visible to the naked eye, it would stretch across the sky like 40 full moons lined up side by side. Shaped like a crescent, it sits delicately at the boundary of a massive cavity surrounding our solar system, known as the Local Bubble.
What is a molecular cloud?
Molecular clouds like Eos are stellar nurseries. They consist mostly of hydrogen gas and cosmic dust, which are the raw ingredients for star and planet formation. These clouds act as cradles of creation in the universe. But until now, the processes within them, especially at the early stages, have remained largely a mystery.
"When we look through our telescopes, we catch whole solar systems in the act of forming, but we don't know in detail how that happens," Burkhart explained. "Our discovery of Eos is exciting because we can now directly measure how molecular clouds are forming and dissociating, and how a galaxy begins to transform interstellar gas and dust into stars and planets."
Eos gives a rare chance to observe these foundational cosmic processes in real-time and with clarity. Scientists believe the cloud has been slowly forming on the edge of the Local Bubble, a 1,000-light-year-wide region of hot, low-density gas that our Sun currently resides in. And while Eos is stable now, it won't last forever, and it is expected to dissipate within the next six million years.
Researchers say that the material has traveled through time for 13.6 billion years, dating all the way back to the Big Bang itself. This makes the cloud not only a massive structure but also a cosmic time capsule composed of some of the oldest matter in existence.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What is RSV and why are infants especially at risk in India?
What is RSV and why are infants especially at risk in India?

Time of India

timean hour ago

  • Time of India

What is RSV and why are infants especially at risk in India?

Respiratory Syncytial Virus, commonly known as RSV, is the leading cause of respiratory illness in children and infants worldwide. In India, RSV has also become a major issue for parents as well as pediatricians, particularly in the post-monsoon and winter seasons when cases surge. Although the nation continues to establish complete surveillance information, existing studies in tertiary care facilities show that RSV contributes 30% to 50% of bronchiolitis and pneumonia incidents in children aged two years and below. RSV is usually responsible for the symptoms of a cold in older children and adults. Nevertheless, in infants—especially those under six months of age, those who were premature at birth, or those with underlying health issues—the virus may cause severe lower respiratory tract infections, including bronchiolitis (inflammation of small airways) and pneumonia. These two diseases usually require hospitalization, and hospitalization rates between 3 and 5 per 100 infants less than one year of age per year have been estimated in India. The risks are not equal throughout the nation. Geographic and socioeconomic variations account for both the risk of and outcome of RSV infection. Children living in lower-income populations or in densely populated urban environments can have increased exposure from lesser access to healthcare, suboptimal ventilation, and slower diagnosis. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Eat 1 Teaspoon Every Night, See What Happens A Week Later [Video] getfittoday Undo Seeing the international burden of RSV, the World Health Organization (WHO) recently supported maternal RSV vaccination as a prevention approach. This entails immunizing pregnant women so that antibodies are passed on to the unborn child, providing immunity in the vulnerable early months of life. Although not yet included in India's Universal Immunization Programme (UIP), Indian health authorities, such as the Indian Academy of Pediatrics, are in the process of evaluating the vaccine's safety, effectiveness, and affordability in India. Phased introduction in high-risk groups could be the initial step. Apart from vaccines, monoclonal antibodies too have been promising in the prevention of RSV-related complications. These provide passive immunity in a single dose of injection. But the big constraint is cost. Without government incentives or being covered under public health schemes, these therapies could prove to be out of reach for the majority of Indian families. Differential pricing models and collaborations with insurance companies will become paramount in order to expand access. More encouragingly, Indian drug makers are not idle either. Bharat Biotech and Serum Institute of India have initiated RSV research programs and are likely to bank on their experience in the production of pediatric and maternal vaccines. Tie-ups with global firms can also open the way for local production of monoclonal antibodies, leading to costs savings as well as wider availability. Experts put wide availability of RSV vaccines and antibodies in India at least 2 to 4 years down the road. Early access could start in corporate or private hospitals dealing with high-risk pregnancies. In the private sector, however, the incorporation of RSV prevention in the national immunization program will be crucial to making RSV vaccines and antibodies accessible and beneficial for all Indian infants—irrespective of birthplace. Article courtesy: Dr. Shreya Dubey - Consultant - Neonatology & Paediatrics, CK Birla Hospital, Gurugram Russia's Lavrov Sounds Alarm Over German Army Buildup Plan; 'Very Worrying, Need To…' One step to a healthier you—join Times Health+ Yoga and feel the change

Russia patents drone tech: Orbital station to launch spacecraft automatically; robots to maintain station
Russia patents drone tech: Orbital station to launch spacecraft automatically; robots to maintain station

Time of India

time2 hours ago

  • Time of India

Russia patents drone tech: Orbital station to launch spacecraft automatically; robots to maintain station

Russia patents space technology, uses robots for maintenance of orbital stations (Representative image: PTI) Russia has developed and patented a new technology that allows spacecraft to be launched automatically from an orbital station, Russian news agency TASS reported. This system also includes robotic maintenance features, making it the first of its kind in the world. The technology will be tested at the upcoming Russian Orbital Station (ROS), and later used in future lunar exploration missions . Russia's first deputy Prime Minister Denis Manturov informed President Vladimir Putin about the developments of this technology, emphasising at Russia's need to transition to its own orbital station, module-by-module by 2030. The ROS 'will become the world's first drone platform equipped with robots for its maintenance. This is a patented solution of the Russian Federation,' Manturov said during the meeting on Friday, as reported by PTI. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo The meeting was chaired by Putin through a televised medium to assess the current national projects, particularly in the field of space. Work is currently underway to develop the Russian Orbital Station (ROS), which is planned for deployment in a near-polar orbit between 2027 and 2033. The scientific and power module (SPM), representing the first segment of the ROS, is scheduled for launch at the end of 2027. By 2030, additional components including the universal-node, gateway, and base modules are planned for launch, which together with the SPM will form the station's core infrastructure. The second phase of the station's deployment will involve expanding the facility by docking two target modules between 2031 and 2033. The deployment of Russia's orbital station is expected to begin after the scheduled deorbiting of the International Space Station by 2030. This transition comes after valuable joint space collaboration experience between Roscosmos and Nasa.

Indian-American teen develops app that can detect early signs of heart disease in just seven seconds
Indian-American teen develops app that can detect early signs of heart disease in just seven seconds

Time of India

time3 hours ago

  • Time of India

Indian-American teen develops app that can detect early signs of heart disease in just seven seconds

Image credits: X/@OddityCentral In the United States an estimated 48% of adults or 121.5 million people, have some form of cardiovascular disease according to the American Heart Association. Cardiovascular diseases which include heart attack and stroke are the No. 1 killer worldwide, responsible for about 32% of global deaths. The risk of these deaths can be reduced with earlier detection. Now, a 14-year-old from Frisco, Texas, has developed a ground-breaking smartphone app to detect early signs of heart disease in just seven seconds. Circadian AI, the app records heart sounds, filters out ambient noise and analyses the data using a cloud-based machine learning model- all by placing a smartphone near the chest. The app identifies arrhythmias, irregular heartbeats, early signs of heart failure, indicators of coronary artery disease and heart valve abnormalities. Siddharth Nandyala's motivation stemmed from his desire to use AI to help people and revolutionize the healthcare system. 'What really took my interest in the healthcare side of artificial intelligence was the sheer amount of impact and the change that can be made,' he told the Smithsonian magazine. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Device Made My Power Bill Drop Overnight elecTrick - Save upto 80% on Power Bill Pre-Order Undo 'Even one life detected is one life saved' he added. Image credits: X/@HYBRIDMINDS3047 He spent months gathering data from hospitals in the US and India and collaborated with medical professionals and patients to refine his app. The clinical trials for his app involved approximately 15,000 patients in the US and around 3,500 in India with the app achieving over 96% accuracy in detecting heart abnormalities, as per Nandyala. Currently, the app is intended only for clinical use by trained personnel, as it requires proper understanding to operate effectively. Nandyala emphasized that it is a pre-screening tool and not a replacement for traditional diagnostic methods like EKGs. Medical professionals praised the app's potential to advance medical care, especially in areas with limited access to healthcare. 'An early potential diagnosis in patients who otherwise may not have had access to medical care may ultimately reduce long-term morbidity and mortality from this condition,' Jameel Ahmed, an electrophysiologist at Louisiana State University, told the magazine. For the 14-year-old, this is not his first innovative work of technology. He previously designed a low-cost prosthetic arm and founded STEM IT- a startup that creates science and technology kits for students. His work has earned him a Certificate of Recognition from the US House of Representatives and a letter of congratulations from then-President Joe Biden . The young innovator is already a freshman studying computer science at the University of Texas. He hopes to expand the app's capabilities to detect lung-related illnesses pneumonia and pulmonary embolism using similar techniques.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store